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Abstract The cellular receptor for subgroup A avian leukosis
and sarcoma virus (ALSV-A) is Tva, which contains a motif
related to repeats in the low density lipoprotein receptor (LDLR)
ligand binding repeat (LBr) and which is necessary for viral
entry. As observed with LBr repeats of LDLR, the 47 residue
LBr domain of Tva (sTva47) requires calcium during oxidative
folding to form the correct disulfide bonds, and calcium enhances
the structure of correctly oxidized sTva47, as well as its ability to
bind the viral envelope protein (Env). However, solution nuclear
magnetic resonance studies indicate that, even in the presence of
excess calcium, sTva47 exists in an ensemble of conformations.
Nonetheless, as reported here, the structure of the predominant
sTva47 solution conformer closely resembles that of other LBr
repeats, with identical S^S binding topology and octahedral
calcium coordination. The location of W48 and other critical
residues on the surface suggests a region of the molecule
necessary for Env binding and to mediate post-binding events
important for ALSV-A cell entry. ß 2001 Federation of Euro-
pean Biochemical Societies. Published by Elsevier Science B.V.
All rights reserved.
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1. Introduction
Enveloped viruses must fuse their viral membrane with the
membrane of the host cell to initiate a productive infection. In
retroviruses this membrane fusion is carried out by the viral
envelope fusion glycoprotein (Env), which is composed of sur-
face (SU) and transmembrane (TM) subunits that form a
trimer of SU/TM heterodimers. Env binds to cellular recep-
tors through the SU subunit, mediating viral attachment, and
generally de¢ning target speci¢city. In many cases, following
the initial interaction between Env and a cellular receptor,
internalization from the cell surface is triggered by interaction
with another cellular receptor (e.g. the human immunode¢-
ciency virus) or through endosomal internalization. A two-
step conformational change mechanism is generally involved
in converting Env to the fusogenic state. Initially, the surface
subunits are partially disassembled (either by receptor binding
or reduction in pH in an endosomal compartment), which act
to prime Env to undergo further conformational change. Fi-
nal conversion to the fusogenic state is mediated by interac-
tion with an additional receptor or a (further) drop in pH [1].
By contrast with the in£uenza A virus, which, upon endo-
somal internalization, uses the decrease in pH to trigger viral
entry [2,3], most retroviruses are believed to use a pH-inde-
pendent mechanism where receptor binding directly triggers
viral entry. Because of its apparent simplicity (i.e. utilization
of a single receptor), the avian leukosis sarcoma virus (ALSV)
has become a model system to study pH-independent viral cell
entry. Surprisingly, recent data suggest that, for ALSV cell
entry, receptor binding must be followed by a decrease in
pH [4]. In any case, for ALSV, receptor binding serves to
drive conformational changes necessary for viral cell entry.
The ALSV family is comprised of ¢ve major subgroups (A^
E), that di¡er in host range, receptor binding, and interference
patterns [5]. The receptor for subgroup A ALSV (Tva) has
been cloned from both quail [6] and chicken [7] and shown to
be necessary for ALSV-A cell entry [7]. Tva encodes a small
(83 amino acids (aa)) ectodomain that contains a single copy
of a cysteine-rich motif ¢rst identi¢ed as seven repeats in the
ligand binding domain of the low density lipoprotein receptor
(LDLR) [6]. This V40 aa LDLR ligand binding repeat (LBr)
is su⁄cient to reconstitute ALSV-A cell entry [8]. Mutational
analysis of the cysteines in the Tva LDLR LBr suggested a
¢rst^third, second^¢fth, and fourth^sixth disul¢de bonding
pattern [9], which matches that later determined for the LBr
of LDLR [10^12]. Intriguingly, further mutational analysis
has suggested that tryptophan 48 (W48) serves a critical role
in post-binding events required for the viral fusion protein to
assume a liposome binding conformation [13] and for viral
cell entry [14].
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The binding of low density lipoprotein to the LDLR is de-
pendent on the presence of calcium [15]. Further, the LBr of
LDLR receptor family requires calcium during oxidative fold-
ing to selectively form the correct disul¢de bonds [11,16^18]
and calcium stabilizes their structures [19^22]. We have shown
a similar requirement for calcium in the bacterially expressed
soluble Tva LBr (sTva47) from the quail sequence. Calcium
was necessary for the selective formation of the correct disul-
¢de bonds during oxidative folding and enhanced its structur-
al stability, as also observed by Wang et al. [23]. We have also
measured the binding of sTva47 to an ALSV-A SU-immu-
noadhesin to be enhanced V30-fold by the presence of cal-
cium.
In this communication we present the three-dimensional
(3D) structure of the major solution conformation assumed
by sTva47 with excess calcium, solved using heteronuclear
nuclear magnetic resonance (NMR) techniques. Not surpris-
ingly, we found that it closely resembles that of LDLR LBr
domains, especially in the C-terminal half that shows the most
sequence similarity and contains a calcium binding site. In
fact, although calcium was not explicitly included during
structural re¢nement, the four conserved acidic side chains
and two backbone carbonyl oxygen atoms were restricted by
the NMR restraints to a correct position for octahedral coor-
dination. The structure reveals that residues known to be
important for binding comprise and cluster around a hydro-
phobic patch on the receptor surface.
2. Materials and methods
2.1. Construction of sTva expression vectors
The quail Tva LDLR LBr (Tva residues 11^51, Fig. 1) was sub-
cloned into pBluescript (Stratagene) using PCR to introduce an in-
frame 5P BamHI and 3P stop codon and EcoRI site. These restriction
sites were further used to subclone into pET12a (Stratagene) or mal-
tose binding protein (MBP)-fusion pMAL (New England Biolabs)
vectors. All constructs were veri¢ed by sequencing.
2.2. Expression and puri¢cation of MBP^sTva47
The cytoplasmic MBP^sTva47 fusion yielded the best expression
(V40% of total soluble protein) and was subsequently utilized,
although the subcloning protocol leaves six residues (ISEFGS) on
the N-terminus of the 41 aa Tva LBr after factor Xa release from
MBP. Expression and puri¢cation were performed essentially follow-
ing the recommended protocol. However, it was necessary to incor-
porate an anion exchange step prior to a⁄nity puri¢cation. Clari¢ed
extract was loaded onto a HiTrap Q column (Pharmacia), washed and
eluted with a 0^1 M NaCl gradient (MBP^sTva47 elutes in a broad
peak from 150 to 450 mM). Because approximately half of the total
expressed MBP^sTva47 is found in the £ow through and wash from
the amylose (a⁄nity) column, these were combined, diluted 1:1 with
bu¡er, and rerun over the HiTrap Q and amylose columns, as above.
2.3. Oxidation and proteolytic release of sTva47
Oxidation of sTva47 was routinely performed in the context of the
fusion protein. Puri¢ed MBP^sTva47 was diluted to A280 = 0.5 with
bu¡er and oxidized by the addition of 3 mM reduced glutathione, 0.3
mM oxidized glutathione, and 5 mM CaCl2, followed by incubation
at 4‡C for at least 12 h [10^12]. Oxidized sTva47 could be released
from MBP with factor Xa (New England Biolabs) cleavage and sep-
arated by ultra¢ltration through a 10 kDa molecular weight cuto¡
membrane (Amicon). The released sTva47 in the ¢ltrate was then
polished on a preparative scale C18 reversed phase column (Vydac)
using a Pharmacia AKTA HPLC. Fractions containing sTva47
(s 99% purity as judged by electrospray mass spectrometry) were
pooled and lyophilized. This lyophilized protein was brought up
into the appropriate bu¡ers and concentrations determined using
the calculated extinction coe⁄cient, O= 12 900 M31 cm31.
2.4. Surface plasmon resonance binding studies
Binding studies were carried out using a BIAcore (BIAcore AB)
with the MBP^sTva47 fusion immobilized (the relatively much larger
MBP provided a means to leave sTva47 largely free of potentially
interfering surface e¡ects). Oxidized MBP^sTva47 was immobilized
following the recommended protocol (Pharmacia BioSensor). All
binding experiments were performed using degassed and 0.2 W ¢ltered
HEPES-bu¡ered saline (HBS; 10 mM HEPES, 150 mM NaCl) and
either 2.5 mM EDTA (ethylenediaminetetraacetate) or 5 mM CaCl2,
with freshly added 0.0005% P20 surfactant, as the running bu¡er.
ALSV-A SU-immunoadhesin (SU(A)-rIgG) fusion protein was dia-
lyzed into HBS+2.5 mM EDTA and diluted ¢ve-fold into either the
same or HBS+5 mM CaCl2 and the concentration determined by A280
using the calculated extinction coe⁄cient, O= 99 920 M31 cm31 (P20
surfactant was added to 0.0005% prior to use). Injections of 10 mM
HCl were used to regenerate the binding surfaces before and between
injections of SU(A)-rIgG.
2.5. NMR structural determination of sTva47
Labeled sTva47 was obtained from expression in appropriately la-
beled minimal media (M9) culture. Expression, puri¢cation, and ox-
idation were carried out as described above. An NMR sample was
then prepared withV2 mM 15N,13C-labeled sTva47 in 50 mM d3-Na-
acetate, 5 mM CaCl2 and 10% D2O at pH 5.5. Preliminary NMR
experiments were carried out a Bruker DMX 600 MHz spectrometer,
while standard two-dimensional (2D) and 3D heteronuclear experi-
ments for structure elucidation were acquired at 15‡C on a Varian
Unity 600 MHz spectrometer using sequences from the ProteinPack
package available online from the Varian user library. All NMR ex-
periments were processed using nmrPipe [24] and visually analyzed
and manipulated with the locally developed program Sparky 3
(Tom Goddard and Don Kneller, University of California, San Fran-
cisco, CA, USA).
2D-15N-heteronuclear single quantum coherence spectra (HSQC),
3D-HNCACB, 3D-CBCA(CO)NH experiments were used to assign
all amide 1H, amide 15N, 13CK and 13CL resonances following stan-
dard techniques for backbone assignments [25,26]. 2D-13C-HSQC
with the carrier frequency centered in the 13C aliphatic region, 3D-
C(CO)NH, 3D-HC(CO)NH and 3D-HCCH-correlation spectroscopy
spectra were then used to assign the remaining aliphatic side chain 1H
and 13C resonances. Aromatic side chain resonances were also as-
signed by using a 2D-13C-HSQC spectrum centered in the 13C aro-
matic region and by inspecting cross-peak connectivities in 2D- and
3D-nuclear Overhauser enhancement spectroscopy (NOESY) experi-
ments.
Restraints for structural calculation were extracted from three 3D-
NOESY experiments: a NOESY-15N-HSQC spectrum and two NO-
ESY-13C-HSQC spectra, one centered in the 13C aliphatic region and
the other in the 13C aromatic region. All NOESY experiments were
acquired using a 200 ms mixing time to allow NOE intensities to build
up. The program Sparky was used to measure the volumes of NOE
cross-peaks by integration. A total of 481, 880 and 128 NOE cross-
Fig. 1. Tva contains an LBr. Alignment of Tva LBr (quail and
chicken, qTva and cTva, respectively) with previously characterized
LBr from human LDLR (hLDLR) and human LDLR-related pro-
tein (hLRP). Conserved cysteines characteristic of LBr are in bold
with the disul¢de bond pairings connected above the alignment. The
daggers below the alignment indicate the residues involved in calci-
um chelation (V, coordination by backbone carbonyl; 2, coordina-
tion by side chain carboxyl) as suggested by the crystal structure of
hLDLR LBr5 [21].
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peak volumes were extracted from the NOESY-15N-HSQC, NOESY-
13C-aliphatic-HSQC and NOESY-13C-aromatic-HSQC spectra, re-
spectively. The CALIBA macro of DYANA 1.5 [27] was then used
to convert the integrated volumes to upper distance limits. Pseudo-
atom corrections were introduced where stereospeci¢c assignments
were not available [28]. Lower bounds were also added to help de¢ne
the structure and were conservatively set to 2.0 Aî below the corre-
sponding upper bounds. Furthermore, during the structural re¢ne-
ment process, negative restraints (lower bounds set to 4.0 Aî for pro-
ton pairs that show no NOE cross-peaks in the spectra) were also
introduced to eliminate unrealistic close contacts found in preliminary
structures [29,30].
These upper and lower bounds were used in DYANA 1.5 [31] and
AMBER-6 [32] to re¢ne the structure of sTva47. One hundred struc-
tures were ¢rst calculated with DYANA using a simulated annealing
cycle of 10 000 torsion angle dynamic steps to yield each structure.
The 20 structures with the lowest target function were imported into
AMBER and further re¢ned by running several consecutive cycles of
simulated annealing. The ¢rst six simulated annealing cycles were 60
ps long with 12 ps high temperature periods at 1000 K to help over-
come local energy barriers. These were followed by nine consecutive
100 ps long annealing cycles with 20 ps spent at 1000 K, for a total of
15 annealing cycles and 1260 ps of AMBER molecular dynamic sim-
ulations. At the end of each cycle, the experimental distance restraints
were analyzed against the calculated structures to identify and correct
errors in assignments, integration and underestimated upper bounds
due to spin di¡usion. The last frame of the annealing cycle was then
used to restart a new cycle using the newly re¢ned set of distance
bounds. Details of the ¢nal set of restraints are shown in Table 1
and Fig. 2D. The ¢nal structures were obtained by averaging the
coordinates saved during the last 5 ps of equilibration at 300 K of
the last annealing cycle and restrained energy minimized. The force
constant used in AMBER for NOE distance restraints was 20 kcal/
mol; this value was increased to 100 kcal/mol during high temperature
dynamics at 1000 K. During AMBER calculations, a generalized Born
implicit solvation model [33] was used to account for the e¡ects of
water solvation during molecular dynamic simulations, with the salt
concentration set to the actual ion strength of our sample.
NOE cross-peak connectivities and preliminary structural calcula-
tions suggested a unique disul¢de bonding pattern in agreement with
the topology suggested by mutagenic studies [9] and comparison to
other LDLR LBrs. Hence, the three disul¢de bonds were de¢ned for
further structural calculations with DYANA and AMBER. On the
contrary, calcium was not explicitly included as well as no dihedral
angle restraints were used during our simulations. Moreover, the ¢rst
¢ve residues of sTva47 (I5^G9), that show only intraresidue and
short-range NOE contacts, were poorly de¢ned in early calculated
structures and were not included in the calculations that yielded our
¢nal structures. The 20 lowest energy structures of the predominant
conformer of sTva47 have been deposited in the Protein Data Bank
(PDB), along with the NMR constraints and chemical shift assign-
ments (PDB ID code 1K7B).
3. Results and discussion
3.1. sTva47 requires calcium for folding, structure and function
Puri¢ed sTva47 required oxidative folding to form the cor-
rect disul¢de bonds. As was found for oxidation of LBr from
the LDLR family of receptors [12,17,18,20], calcium was re-
quired to selectively form a single disul¢de bonding pattern,
which we assumed matched that of the native Tva and the
LDLR LBr as previously suggested [9] (Wang et al. have
reported similar ¢ndings [23]). After suitable conditions were
de¢ned, oxidation was carried out using puri¢ed MBP^
sTva47 in order to use correctly oxidized sTva47 attached to
MBP for surface plasmon resonance binding experiments (see
below).
Inspection of 15N-HSQC spectra revealed that the addition
of excess (5 mM) calcium dramatically reduces the number
(from s 120 to 84) and increases the dispersion of cross-peaks
in 15N-edited HSQC spectra (data not shown). This indicates
that, even when correctly oxidized, the Tva LBr requires
bound calcium to stabilize its tertiary structure. Similar results
were also found by Wang et al. for Tva [23] and for LBr of
the LDLR family of receptors [12,17,18,20].
ALSV binds to its cellular receptor through the surface
subunit (SU) of its envelope glycoprotein (Env). To quantita-
tively address the ability of sTva47 to bind ALSV-A Env, we
performed surface plasmon resonance binding experiments us-
ing a previously characterized ALSV-A SU-immunoadhesin
(SU(A)-rIgG) fusion [14]. In the absence of calcium (i.e. 2.5
mM EDTA) the binding constant was 5.5 nM. Notably, the
presence of 5 mM calcium increased the a⁄nity of this inter-
action 27.5-fold (Kd = 0.2 nM) (data not shown). This range
of disassociation constants is similar to those previously re-
ported, where the presence of calcium was not quanti¢ed
[14,34]. These results demonstrate that calcium increases the
a⁄nity of sTva47 for the SU of ALSV-A, presumably by
stabilizing its tertiary structure, as detailed below. This re-
quirement for calcium for oxidative folding, structural stabil-
ity, and receptor binding is consistent with the results of stud-
ies of LBr from the LDLR family of receptors [12,16^18,20^
22].
3.2. Structural characterization of sTva47
Surprisingly, the 15N-HSQC spectrum of properly folded
sTva47 acquired in the presence of excess calcium shows a
larger number of cross-peaks than expected (Fig. 2A), indicat-
ing the presence of multiple conformations which do not in-
terconvert within the NMR time scale. Changes in the pH,
protein concentration, salt concentration (including calcium
concentration) and temperature (15^35‡C range) of the sam-
ple did not seem to favor one set of cross-peaks over others.
Resonance assignments revealed three sets of cross-peaks
for some residues indicating the presence of three di¡erent
conformers (Fig. 2A). Plotting the chemical shift di¡erence
between the three conformers for each residue (Fig. 2B)
showed that this conformational £exibility is localized to the
loop region between C18 and C28 with the largest deviations
found around two adjacent proline residues: P21 and P22.
This observation suggested that a cis^trans isomerization
Table 1
Constraint and structural statistics
No. of NOE distance restraints
Intraresidue (i = 0) 120
Short-range (i = 1) 346
Medium-range (16 i6 4) 268
Long-range (is 4) 282
Total 1016






In favored (%) 63.9
In additional allowed (%) 35.0
In generously allowed (%) 1.1
Restraint satisfaction
rms violation (Aî ) 0.041 þ 0.0001
Maximum NOE violation 0.286
Average no. of NOE violations 23
aMOLMOL [40] was used to determine rmsd values for overlays.
bProcheck-NMR [41] was used to generate Ramachandran plots to
assess the quality of the structures.
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equilibrium about the peptide bonds of P21 and P22 may
be responsible for the multiple conformers. This hypothesis
was demonstrated and the con¢guration of the two peptide
bonds in the three conformers determined by analyzing
HK(i)^HK(i+1) and HK(i)^HN(i+1) NOE connectivities be-
tween residues E20^P21 and P21^P22. The conformers were
found to have trans^trans, trans^cis and cis^trans con¢gura-
tion about the P21 and P22 peptide bonds, respectively, with
the trans^trans conformer being the most abundant one,
based on the relative intensities of 15N-HSQC cross-peaks.
In this manuscript we report the structure of the predominant
trans^trans conformer. We note that this conformational £ex-
ibility seems to be restricted to the C18^C28 loop in the
N-terminal half of Tva, far away from the putative binding
site of the viral envelope glycoprotein. Moreover, the two
proline residues undergoing cis^trans isomerization have
been mutated without impairing the ability of Tva to function
as a receptor for ALSV-A [35^37]. Thus, we conclude that
while this prolyl isomerization process is a signi¢cant struc-
tural property of the quail Tva, it does not play an important
role in viral receptor functionality.
In general, the root mean square deviation (rmsd) values,
energies, geometry and Ramachandran statistics are good for
all the calculated structures of sTva47 (Table 1). The structure
appears to be formed from N- and C-terminal structural do-
mains. The N-terminal domain is folded around the side chain
of R17 (that has NOE contacts to 14 other residues) and is
dominated by the C18^C28 loop with a short two strand
parallel L-sheet at its bottom, also described in other LDLR
LBr structures. This loop, which undergoes the isomerization
process described above, is highly exposed to solvent and less
well de¢ned by NMR restraints. The C-terminal domain, on
the other hand, appears to be better de¢ned with a larger
number of distance restraints, probably due to the stabilizing
Fig. 2. A: 1H^15N HSQC spectrum of sTva47 with assignments. The three di¡erent conformers observed for some residues are labeled x, y
and z, where x refers to the dominant trans^trans conformer whose structure was solved. Cross-peaks from side chain groups were also as-
signed and are explicitly labeled in the ¢gure. Folded peaks are shown with black labels. B: Cartoon representation of sTva47 molecule with
disul¢de bonds and daggers to indicate residues that are involved in calcium coordination (V, coordination by backbone carbonyl; 2, coordina-
tion by side chain carboxyl). The height of the amino acid cylinders is proportional to the chemical shift di¡erence between the three x, y, z
conformers. C: Summary of local constraints used in deriving the structure of sTva47 including disul¢de bonds and short- to medium-range
NOE-derived backbone constraints. Secondary structure and average estimated accessibility are shown at the bottom as well. D: Plot of intra-
residue, short-range (i = 1), medium-range (16 i6 4) and long-range (is 4) NOE distance restraints per residue.
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e¡ect of calcium coordination (Table 1 and Figs. 2 and 3).
The two domains are linked together by the C18^C41 disul-
¢de bond at one end and the backbone of residues Q31^L34,
that form a short 310-helix (also found in other LDLR LBr),
at the other end. In between these is the hydrophobic core of
the protein comprised of the side chains of residues F16, Y29,
P30 and W33. Another short 310-helix (residues W48^C50) is
found at the C-terminus.
The structure of sTva47 was compared to LR5 [21], the ¢fth
repeat of LDLR, chosen to represent the LBr fold. Not sur-
prisingly, given the ! !identical S^S topology and the putative
calcium binding site, the structures are very similar with the
backbone of the C-terminal and part of the N-terminal do-
mains of sTva47 (residues C28^C50) overlapping to 1.0 Aî of
the corresponding LR5 residues (C17^C39) (Fig. 4A). More-
over, the rmsd value decreases to 0.6 Aî if only the C-terminal
domain is considered (L34^G49 of sTva47 overlapped to
R23^N38 of LR5). The main di¡erences between the struc-
tures are in the N-terminal domain, mainly because of the 5 aa
longer C18^C28 loop found in sTva47 compared to LR5. This
is also the region of Tva that undergoes prolyl isomerization.
The acidic side chains of D36, D40, D46 and E47, and the
two backbone carbonyl oxygen atoms from residues L34 and
H38, are correctly positioned by the NMR restraints to coor-
dinate calcium. Together they form an octahedral cage,
closely resembling the calcium binding site found in LR5
(Fig. 4B). The distances between opposing oxygen atoms are
somewhat longer than expected, V7 Aî compared to V5 Aî ,
probably because of electrostatic repulsion between their neg-
ative charges in the absence of an explicit calcium atom dur-
ing structural calculations. Given this ¢nding and the impor-
tant role that calcium plays in viral receptor function
described earlier, we conclude that the calcium binding site
found in LDLR LBr is conserved in Tva.
3.3. Implications for viral receptor function
Gain and loss of function studies have pointed to residues
that are important or critical for Tva to act as an ALSV-A
Fig. 3. A: Stereo view of the 20 lowest energy structures of sTva47 superimposed. Backbone atoms (red) are illustrated along with side chains
(green). Disul¢de bonds are shown in yellow. B: Lowest energy structure of sTva47 with secondary structural elements. This ¢gure was pre-
pared with the program MOLMOL [40].
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receptor. Most of these residues are located in the C-terminal
portion of the protein suggesting that this is where the bulk of
the viral binding site is located. Among them are highly con-
served residues that are critical to ensure proper folding of the
LBr module of Tva: D46 and E47, whose acidic side chains
coordinate calcium [23,37], and C35 and C50, that form a
disul¢de bridge [9]. Mutations of these residues most likely
exert their e¡ect by disrupting the Tva structure at the viral
binding site.
Other important amino acids (W48, G49, L34 and H38) are
not conserved within the LBr family and may play a more
direct role in viral receptor function. Perhaps one of the most
interesting of these residues is W48 [13,14,35,37]. Our sTva47
structure shows the aromatic side chain of W48 at the surface
of the protein, lying £at against the backbone and side chain
of R45 (whose 1HK resonance is shifted up¢eld to 2.1 ppm
due to its proximity to the aromatic ring) and to a lesser
extent residues D43 and G44. Its position is well de¢ned by
NMR restraints. Given its exposed location, it is unlikely that
W48 is critical for protein folding and, hence, its functional
importance is most likely to derive from a direct interaction
with the viral envelope glycoprotein. Furthermore, the pres-
ence of a glycine residue adjacent to W48 was also found to
be important for function. While it was hypothesized that a
bulkier side chain might interfere with the correct placement
of the W48 aromatic side chain [36], our structure shows that
position 49 could easily host a bulkier side chain without
altering the conformation of W48. An alternative explanation
is that G49 forms part of the binding surface and its mutation
sterically interferes with Tva contacting the envelope glyco-
protein. This is con¢rmed by the fact that the insertion of two
amino acid residues after G49 (as found in LDLR LB1 and
LB4) also disrupts viral receptor function [36], as if altering
the binding surface.
L34, which some studies found to be critical for Tva recep-
tor function [35,37], seems to play an important role for pro-
tein folding, since, as expected [23], it is mostly buried in the
hydrophobic core of the protein. However, together with the
highly conserved residue F16, L34 also forms a hydrophobic
patch on the surface of Tva that is adjacent to W48 and may
contact Env-A directly.
Finally, gain of function experiments using a bone ¢de
Fig. 4. A: Comparison of the backbone atom coordinates of sTva47 (light blue) and LR5 (red), the ¢fth repeat of LDLR that was chosen as
representative of the LBr domain fold (residues 24^46 of sTva47 were superimposed to residues 17^39 of LR5). B: Comparison of the calcium
binding sites of sTva47 and LR5. The H-bond formed between H38 and D40 of Tva is also shown in green. The coordinates of LR5 were ob-
tained from the PDB (1ajj). Structural comparisons were performed using the program MOLMOL [40].
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LDLR repeat also pointed to H38 playing a role in viral
receptor function [36]. This residue is not conserved among
LBrs and in our structure is at the surface of Tva suggesting
that it interacts directly with the envelope glycoprotein. H38,
however, also seems to be important for calcium coordina-
tion, as it provides one of the two backbone carbonyl oxygen
atoms that bind calcium and its aromatic side chain forms a
H-bond to the acidic side chain of D40, which also coordi-
nates the calcium ion (Fig. 4B).
Although most of the work done so far points to the viral
binding site being near the C-terminus of the Tva LBr do-
main, there have been indications that residues from the
N-terminal domain of the molecule may also play a minor
role in viral receptor function [37]. In a recent report, three
mutations in the hr1 region of the SU subunit of Env-A,
E149K, Y142N and Y142N/E149K, were found to reduce
the binding a⁄nity for quail but not chicken sTva [38]. Since
the C-terminal halves of chicken and quail Tva are identical,
these results point to a positively charged residue present in
the quail but not chicken N-terminal domain of Tva that
contacts the hr1 region of Env-A (Fig. 1). A possible candi-
date is H25, which is Gln in the chicken sequence. Our struc-
ture, however, shows that the H25 side chain is located on the
opposite side of the molecule far away from the putative SU
binding surface. The only other positively charged residue
found in the quail but not chicken sequence is R10, surpris-
ingly just outside the LBr domain (Gln in the chicken se-
quence). Unfortunately our sequence di¡ers from both quail
and chicken in that it has a Ser at this position. Furthermore,
in our structure this Ser is poorly de¢ned both because its
exposure at the surface and its proximity to the disordered
N-terminus. However, it is quite plausible that an Arg residue
at this position could contact Env-A directly. While this in-
teraction may not contribute signi¢cantly to Tva-SU binding
a⁄nity, Env mutations like the ones described above could
readily introduce steric or electrostatic clashes capable of dis-
rupting binding of quail Tva to Env-A.
3.4. Analysis of Tva surface
Inspection of the molecular surface of Tva reveals a hydro-
phobic patch at the C-terminus, composed of residues W48
and G49, that extends towards the N-terminal domain with
L34, Q31 and F16 (Fig. 5A). The other side of the C-terminal
domain is highly polar (Fig. 5B,C) with the positively charged
H38 residue surrounded by negatively charged acidic side
chains. The viral binding site is most likely centered around
residues W48^G49, extending on one side towards H38 and
on the other towards the hydrophobic patch formed by L34
and F16. In between W48, G49 and H38 we ¢nd the acidic
side chain of E47 which also coordinates calcium. Being lo-
cated in such a hot spot at the Tva surface suggests that E47
may also play a more direct role in viral receptor function,
perhaps by interacting with those basic residues on the hr2
region of Env-A that mutagenic studies found to be important
for Tva binding [39].
Fig. 5. A^C: Molecular surface of the sTva47 structure colored by
electrostatic potential. In B and C, the modules are rotated V90‡
around the vertical axis. This ¢gure was prepared with the program
MOLMOL [40].
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4. Conclusions
We have functionally and structurally characterized sTva47,
a 47 aa peptide that contains the LBr domain of Tva that is
su⁄cient and necessary to interact with ALSV-A and trigger a
change in conformation of Env. The 3D structure of sTva47 is
remarkably similar to that of other LBr domains, with iden-
tical S^S topology and a conserved calcium binding site near
the C-terminus. Furthermore, all the residues that are known
to be important for viral receptor function are clustered in the
C-terminal half of the molecule. These ¢ndings explain our
observations that calcium is required for oxidative folding,
structural stability and also its ability to increase the a⁄nity
of Tva for Env-A. Finally, surface analysis points to a puta-
tive binding site in the C-terminal domain of Tva where im-
portant and critical residues (W48, G49, H38, L34 and E47)
are exposed at the surface and likely to interact directly with
the viral envelope glycoprotein.
Acknowledgements: We thank Dr. A. Weiss (UCSF/HHMI) for use of
a BIAcore, Dr. C. Turck (UCSF/HHMI) for use of a LCQ (Finnigan)
mass spectrometer, Dr. J.A.T. Young (Harvard Med) for providing
SU(A)-rIgG, Dr. T.M. Handel for use of a Bruker DMX 600 MHz
spectrometer for preliminary NMR analysis, Dr. V. Basus for help
acquiring NMR experiments on a Varian Unity 600 MHz spectrom-
eter and Dr. C. Kojima for helpful discussions. This work was sup-
ported by the Howard Hughes Medical Institute and NIH Grant
GM39247 (T.L.J.).
References
[1] White, J.M. (1992) Science 258, 917^924.
[2] Carr, C.M., Chaudhry, C. and Kim, P.S. (1997) Proc. Natl.
Acad. Sci. USA 94, 14306^14313.
[3] Bullough, P.A., Hughson, F.M., Skehel, J.J. and Wiley, D.C.
(1994) Nature 371, 37^43.
[4] Mothes, W., Boerger, A.L., Narayan, S., Cunningham, J.M. and
Young, J.A.T. (2000) Cell 103, 679^689.
[5] Vogt, P.K. (1977) in: Comprehensive Virology (Fraenkel-Conrat,
H. and Wagner, R., Eds.), Vol. 9, pp. 341^455, Plenum, New
York.
[6] Bates, P., Young, J.A.T. and Varmus, H.E. (1993) Cell 74, 1043^
1051.
[7] Young, J.A.T., Bates, P. and Varmus, H.E. (1993) J. Virol. 67,
1811^1816.
[8] Rong, L. and Bates, P. (1995) J. Virol. 69, 4847^4853.
[9] Belanger, C., Zingler, K. and Young, J.A.T. (1995) J. Virol. 69,
1019^1024.
[10] Bieri, S., Djordjevic, J.T., Daly, N.L., Smith, R. and Kroon, P.A.
(1995) Biochemistry 34, 13059^13065.
[11] Bieri, S., Djordjevic, J.T., Jamshidi, N., Smith, R. and Kroon,
P.A. (1995) FEBS Lett. 371, 341^344.
[12] Blacklow, S.C. and Kim, P.S. (1996) Nat. Struct. Biol. 3, 758^
761.
[13] Hernandez, L.D., Peters, R.J., Delos, S.E., Young, J.A.T.,
Agard, D.A. and White, J.M. (1997) J. Cell Biol. 139, 1455^
1464.
[14] Zingler, K. and Young, J.A.T. (1996) J. Virol. 70, 7510^7516.
[15] Goldstein, J.L. and Brown, M.S. (1974) J. Biol. Chem. 249,
5153^5162.
[16] Atkins, A.R., Brereton, I.M., Kroon, P.A., Lee, H.T. and Smith,
R. (1998) Biochemistry 37, 1662^1670.
[17] North, C.L. and Blacklow, S.C. (1999) Biochemistry 38, 3926^
3935.
[18] Dolmer, K., Huang, W. and Gettins, P.G.W. (1998) Biochemistry
37, 17016^17023.
[19] North, C.L. and Blacklow, S.C. (2000) Biochemistry 39, 2564^
2571.
[20] Bieri, S., Atkins, A.R., Lee, H.T., Winzor, D.J., Smith, R. and
Kroon, P.A. (1998) Biochemistry 37, 10994^11002.
[21] Fass, D., Blacklow, S., Kim, P.S. and Berger, J.M. (1997) Nature
388, 691^693.
[22] Huang, W., Dolmer, K. and Gettins, P.G.W. (1999) J. Biol.
Chem. 274, 14130^14136.
[23] Wang, Q.-Y., Dolmer, K., Huang, W., Gettins, P.G.W. and
Rong, L. (2001) J. Virol. 75, 2051^2058.
[24] Delaglio, F., Grzesiek, S., Buister, G.W., Zhu, G., Pfeifer, J. and
Bax, A. (1995) J. Biomol. NMR 6, 277^293.
[25] Clore, G.M. and Gronenborn, A.M. (1991) Science 252, 1390^
1399.
[26] Clore, G.M. and Gronenborn, A.M. (1998) Curr. Opin. Chem.
Biol. 2, 564^570.
[27] Guntert, P., Braun, W. and Wuthrich, K. (1991) J. Mol. Biol.
217, 517^530.
[28] Wu«thrich, K., Billeter, M. and Braun, W. (1983) J. Mol. Biol.
169, 949^961.
[29] Yao, L.J., James, T.L., Kealey, J.T., Santi, D.V. and Schmitz, U.
(1997) J. Biomol. NMR 9, 229^244.
[30] Schmitz, U., Donati, A., James, T.L., Ulyanov, N.B. and Yao, L.
(1998) Biopolymers 46, 329^342.
[31] Guntert, P., Mumenthaler, C. and Wuthrich, K. (1997) J. Mol.
Biol. 273, 283^298.
[32] Cornell, W.D. et al. (1995) J. Am. Chem. Soc. 117, 5179^
5197.
[33] Tsui, V. and Case, D.A. (2000) J. Am. Chem. Soc. 122, 2489^
2498.
[34] Balliet, J.W., Berson, J., D’Cruz, C.M., Huang, J., Crane, J.,
Gilbert, J.M. and Bates, P. (1999) J. Virol. 73, 3054^3061.
[35] Zingler, K., Belanger, C., Peters, R.J., Agard, D.A. and Young,
J.A.T. (1995) J. Virol. 69, 4261^4266.
[36] Rong, L., Gendron, K. and Bates, P. (1998) Proc. Natl. Acad.
Sci. USA 95, 8467^8472.
[37] Rong, L., Gendron, K., Strohl, B., Shenoy, R., Wool-Lewis, R.J.
and Bates, P. (1998) J. Virol. 72, 4552^4559.
[38] Holmen, S.L., Melder, D.C. and Federspiel, M.J. (2001) J. Virol.
75, 726^737.
[39] Rong, L., Edinger, A. and Bates, P. (1997) J. Virol. 71, 3458^
3465.
[40] Koradi, R., Billeter, M. and Wuthrich, K. (1996) J. Mol. Graph.
14, 51^55.
[41] Laskowski, R.A., Rullmannn, J.A., MacArthur, M.W., Kaptein,
R. and Thornton, J.M. (1996) J. Biomol. NMR 8, 477^486.
FEBS 25475 5-12-01 Cyaan Magenta Geel Zwart
M. Tonelli et al./FEBS Letters 509 (2001) 161^168168
